Cited by 144Pituitary Gland Disorders and TreatmentsRegulation of Appetite and ObesityHypothalamic control of reproductive hormones

Hypothalamic syndrome

Open access
Müller, Hermann L., Tauber, Maithé, Lawson, Elizabeth A., Özyurt, Jale, Bison, Brigitte, Martinez-Barbera, Juan-Pedro, Puget, Stephanie, Merchant, Thomas E. +1 more·2022·Nature Reviews Disease Primers

Abstract

Hypothalamic syndrome (HS) is a rare disorder caused by disease-related and/or treatment-related injury to the hypothalamus, most commonly associated with rare, non-cancerous parasellar masses, such as craniopharyngiomas, germ cell tumours, gliomas, cysts of Rathke's pouch and Langerhans cell histiocytosis, as well as with genetic neurodevelopmental syndromes, such as Prader-Willi syndrome and septo-optic dysplasia. HS is characterized by intractable weight gain associated with severe morbid obesity, multiple endocrine abnormalities and memory impairment, attention deficit and reduced impulse control as well as increased risk of cardiovascular and metabolic disorders. Currently, there is no cure for this condition but treatments for general obesity are often used in patients with HS, including surgery, medication and counselling. However, these are mostly ineffective and no medications that are specifically approved for the treatment of HS are available. Specific challenges in HS are because the syndrome represents an adverse effect of different diseases, and that diagnostic criteria, aetiology, pathogenesis and management of HS are not completely defined.

Integrity signals

Registry

Crossref · 10.1038/s41572-022-00351-z

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Other tumors, such as low-grade gliomas and germinomas, also confer increased risk of acquired hypothalamic syndrome.

    “As previously summarized, craniopharyngioma is the prototypic suprasellar tumor leading to acquired hypothalamic syndrome, but other tumors (eg, low-grade gliomas, germinomas) also confer increased risk.”
  • Injury to the hypothalamus, whether from tumors affecting this brain area or their treatment, leads to acquired hypothalamic syndrome in approximately 80% of individuals, depending in large part on tumor characteristics.

    “Injury to the hypothalamus, whether from the tumors affecting this brain area or their treatment, leads to acquired hypothalamic syndrome in approximately 80% of individuals, depending in large part on the tumor characteristics (1, 2).”
  • Other highly morbid symptoms of hypothalamic syndrome include abnormal sleep and circadian function, temperature dysregulation, and behavior changes.

    “Clinicians caring for such patients have also appreciated the presence of other highly morbid symptoms, including abnormal sleep and circadian function, temperature dysregulation, and behavior changes (2).”
  • Craniopharyngioma is the prototypic suprasellar tumor leading to acquired hypothalamic syndrome.

    “As previously summarized, craniopharyngioma is the prototypic suprasellar tumor leading to acquired hypothalamic syndrome, but other tumors (eg, low-grade gliomas, germinomas) also confer increased risk.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Müller, H. L., Tauber, M., Lawson, E. A., Özyurt, J., Bison, B., Martinez-Barbera, J.-P., Puget, S., Merchant, T. E., & van Santen, H. M.
Affiliations
  • Centre National de la Recherche Scientifique (FR)
  • Harvard University (US)
  • Carl von Ossietzky Universität Oldenburg (DE)
  • University Hospital Augsburg (DE)
  • St. Jude Children's Research Hospital (US)
Venue
Nature Reviews Disease Primers
Published
2022-04-21
Volume
8
Issue
1
Pages
24-24
ISSN
2056-676X (ISSN-L)
OpenAlex
W4224262686
Cited by
144
References
15
Citations by year
2026: 27 · 2025: 48 · 2024: 31 · 2023: 24 · 2022: 13 · 2021: 1
FWCI
4.12
Type
journal article
Language
en
Open access
Locations
  • Nature Reviews Disease Primers (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
  • Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
  • UCL Discovery (University College London) (submittedVersion)
  • OPUS (Augsburg University) (submittedVersion)
Funders
  • Cancer Research UK (27727)
  • CHILDREN with CANCER UK (15/190)
  • Brain Tumour Charity (GN-000382)
  • Medical Research Council (MR/M000125/1)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
  • Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
Keywords
hypothalamic syndrome, hypothalamic injury, morbid obesity, craniopharyngioma, germ cell tumors, Langerhans cell histiocytosis, Prader-Willi syndrome, septo-optic dysplasia, endocrine disorders, memory impairment, obesity treatment, pathophysiology, diagnosis, prevention
MeSH terms
Craniopharyngioma, Endocrine System Diseases, Humans, Hypothalamus, Pituitary Neoplasms, Prader-Willi Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review